Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Standards & Regulation

Manufacture Standards & Regulation

Quality, Not Quantity

| Iain Moore

Qualitative risk assessments are a great way to approach quality management and train your operators at the same time.

Business & Regulation Small Molecules

And for 2020...

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2020 Power List.

Manufacture Standards & Regulation

A Continuous Cycle of Success

| David Thompson

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

Business & Regulation Standards & Regulation

The IPEC Story: Promoting Ingredients for Success

| With David Schoneker

High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry.

Business & Regulation Standards & Regulation

Cutting Out the Middleman

| Maryam Mahdi

What are the consequences of allowing patients to purchase cell and gene therapies directly from hospitals?

Business & Regulation Contract Manufacturing Services

(Block)chain Reaction

| Heather Zenk

Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.

Business & Regulation Standards & Regulation

So Long and Thanks for all the Drugs

| Stephanie Sutton

Scott Gottlieb prepares to leave the FDA after accomplishing much.

Business & Regulation Standards & Regulation

Tax Credits: Your Work is Worth it

| Peter Beavis

Research and development tax reliefs are available for businesses in many countries, but some companies are not taking advantage.

Business & Regulation Standards & Regulation

A Fairer Playing Field

| Maryam Mahdi

A recently published report shows how the European Commission has protected patients against anticompetitive practices over the last decade.

Business & Regulation Quality & Compliance

Batch Relief

| James Strachan

EU will allow companies to carry out QC testing in the UK after a "no deal" Brexit, at least under certain conditions and for a limited time.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

Characterization of the size and concentration of liposomes

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register